2 completed, 1 withdrawn. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
| Phase 3 | 2 | Completed 2 |
Follow balugrastim: new trials by email Literature Review of balugrastim trials Research Report on balugrastim
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors Balugrastim, Filgrastim - Solid Tumors | Phase 2 | Withdrawn | Teva Branded Pharmaceutical Products R&D, Inc. | 2014-09-01 | 2015-01-14 | |
| Neugranin in Breast Cancer Participants Receiving Doxorubicin/Docetaxel Neugranin, Pegfilgrastim, Chemotherapy - Chemotherapy-induced Neutropenia | Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 381 | 2010-06-30 | 2023-03-28 |
| Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel Balugrastim, Pegfilgrastim, Chemotherapy Regimen - Chemotherapy-induced Neutropenia | Phase 2 / Phase 3 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 334 | 2008-08-21 | 2024-04-03 |
Teva Branded Pharmaceutical Products R&D, Inc. (3)
Bulgaria (1) · Romania (1) · Russia (1) · Serbia (1) · Ukraine (1)